DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

1INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 327026-93-7, Slv-314, Lensiprazine [inn], N47mw76ogx, Chembl196514, (r)-8-(4-(3-(5-fluoro-1h-indol-3-yl)propyl)piperazin-1-yl)-2-methyl-2h-benzo[b][1,4]oxazin-3(4h)-one

Molecular Formula

C₂₄H₂₇FN₄O₂

Molecular Weight

422.5 g/mol

InChI Key

SDAMYSWGWHXMRT-MRXNPFEDSA-N

FDA UNII

N47MW76OGX

1 2D Structure

Lensiprazine

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2R)-8-[4-[3-(5-fluoro-1H-indol-3-yl)propyl]piperazin-1-yl]-2-methyl-4H-1,4-benzoxazin-3-one

2.1.2 InChI

InChI=1S/C24H27FN4O2/c1-16-24(30)27-21-5-2-6-22(23(21)31-16)29-12-10-28(11-13-29)9-3-4-17-15-26-20-8-7-18(25)14-19(17)20/h2,5-8,14-16,26H,3-4,9-13H2,1H3,(H,27,30)/t16-/m1/s1

2.1.3 InChI Key

SDAMYSWGWHXMRT-MRXNPFEDSA-N

2.1.4 Canonical SMILES

CC1C(=O)NC2=C(O1)C(=CC=C2)N3CCN(CC3)CCCC4=CNC5=C4C=C(C=C5)F

2.1.5 Isomeric SMILES

C[C@@H]1C(=O)NC2=C(O1)C(=CC=C2)N3CCN(CC3)CCCC4=CNC5=C4C=C(C=C5)F

2.2 Other Identifiers

2.2.1 UNII

N47MW76OGX

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 8-(4-(3-(5-fluoro-1h-indol-3-yl)propyl)piperazin-1-yl)-4h-benzo(1,4)oxazin-2-methyl-3-one

2. Slv 314

3. Slv-314

4. Slv314

2.3.2 Depositor-Supplied Synonyms

1. 327026-93-7

2. Slv-314

3. Lensiprazine [inn]

4. N47mw76ogx

5. Chembl196514

6. (r)-8-(4-(3-(5-fluoro-1h-indol-3-yl)propyl)piperazin-1-yl)-2-methyl-2h-benzo[b][1,4]oxazin-3(4h)-one

7. Unii-n47mw76ogx

8. Lensiprazine [who-dd]

9. Dtxsid60186379

10. Bdbm50176019

11. Zinc11689014

12. (2r)-8-[4-[3-(5-fluoro-1h-indol-3-yl)propyl]piperazin-1-yl]-2-methyl-4h-1,4-benzoxazin-3-one

13. 026l937

14. Q27284539

15. (2r)-8-(4-(3-(5-fluoro-1h-indol-3-yl)propyl)piperidin-1-yl)-2-methyl-2h-1,4-benzoxazin-3(4h)-one

16. (2r)-8-[4-[3-(5-fluoro-1h-indole-3-yl)propyl]piperazino]-2alpha-methyl-2h-1,4-benzooxazine-3(4h)-one

17. (r)-8-{4-[3-(5-fluoro-1h-indol-3-yl)-propyl]-piperazin-1-yl}-2-methyl-4h-benzo[1,4]oxazin-3-one

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₂₄H₂₇FN₄O₂
Molecular Weight	422.5 g/mol
XLogP3	3.8
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	5
Exact Mass	422.21180428 g/mol
Monoisotopic Mass	422.21180428 g/mol
Topological Polar Surface Area	60.6 Å²
Heavy Atom Count	31
Formal Charge	0
Complexity	629
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Dopamine D2 Receptor Antagonists

Compounds and drugs that bind to and inhibit or block the activation of DOPAMINE D2 RECEPTORS. (See all compounds classified as Dopamine D2 Receptor Antagonists.)

INTERMEDIATES SUPPLIERS